First Horizon Advisors Inc. increased its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 308.3% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 245 shares of the biotechnology company’s stock after purchasing an additional 185 shares during the period. First Horizon Advisors Inc.’s holdings in Sarepta Therapeutics were […]